New Products

Health Economics Outcomes evaluation of Stago D-dimer

Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.

Read more

Stago proposes a solution for diagnosing Von Willebrand disease: STA-VWF:RCo*

Von Willebrand disease is a bleeding disorder resulting from a qualitative or quantitative deficiency of the von Willebrand factor (VWF).

Read more

Exclusive: A solution for measuring edoxaban!

Stago is pleased to announce our latest innovative products: STA®-Edoxaban Calibrator and STA®-Edoxaban Control. In combination with STA®-Liquid Anti-Xa, they allow the measurement of Edoxaban plasma concentration.

Read more

Diagnostica Stago Announces Canadian Launch of its Second Max Generation Analyzer, the STA R Max®

July 4, 2016, Toronto, ON Canada – Stago Canada, Ltd./Ltée. announced the launch of the STA-R Max® Haemostasis analyser, the newest member of the Max Generation family of Haemostasis analysers.

Read more

Diagnostica Stago Launches New Procoagulant

January 2014, Parsippany, NJ, USA – Diagnostica Stago, Inc. introduces Megamix-Plus SSC (cat # 01078) and Megamix-Plus FSC (cat # 01077), for detection of procoagulant microparticles on both side-scatter and forward-scatter flow...

Read more

 1 2